venous thrombotic events

Related by string. * Venous : intra venous . venous stasis ulcers . Venous stasis ulcers . venous blood clots / Thrombotic : thrombotic thrombocytopenic purpura TTP . anti thrombotic Lovenox . thrombotic disorders malignant neoplasm . anti thrombotic / eventing . EVENTS . EVENT . Events : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement * *

Related by context. Frequent words. (Click for all words.) 60 de ath 60 cerebrovascular diseases 60 cerebral infarction 60 cerebrovascular events 60 myocardial infarction MI 59 myocardial infarctions 59 thrombotic events 59 hemorrhagic strokes 59 ximelagatran 58 ischemic strokes 58 haemorrhagic stroke 57 thromboembolic 57 nonfatal stroke 57 acute coronary 57 systemic embolism 57 thrombolytic therapy 56 intracerebral hemorrhage 56 thromboembolic events 56 ARVD 56 stroke 56 carotid stenosis 56 undergoing coronary artery 56 ischemic stroke 56 cerebrovascular accident 55 alteplase 55 serum uric acid 55 cardio vascular disease 55 myocardial infarction stroke 55 ventricular arrhythmia 55 circulatory diseases 55 ischemic cardiomyopathy 55 experimentally induced 55 cilostazol 55 beta blocker therapy 55 extrapyramidal symptoms 54 eplerenone 54 neurologic symptoms 54 pericardial effusion 54 cardiac dysfunction 54 Ischemic 54 postsurgical 54 nonfatal myocardial infarction 54 hepatic failure 54 nonfatal heart 54 perinatal mortality 54 Cerovive 54 cerebral ischemia 54 thromboembolism 54 fatal myocardial infarction 54 dobutamine 54 coronary intervention 54 atherothrombosis 54 colorectal adenomas 54 cardio vascular diseases 53 olmesartan 53 valvular heart 53 chronic obstructive lung 53 receiving VELCADE 53 hyperbilirubinemia 53 NHANES III 53 tissue plasminogen activator tPA 53 revascularization procedures 53 venous thrombosis 53 DP b# 53 acute coronary syndromes ACS 53 left ventricular systolic 53 lipid lowering therapy 53 cerebrovascular disease 53 myocardial infarction 53 cardiovascular mortality 52 patients undergoing percutaneous 52 cardiovascular hospitalization 52 infarctions 52 % CI #.#-#.# [007] 52 lumiracoxib 52 #mg/day [001] 52 POAG 52 venous thromboembolic events 52 retinal vein occlusion 52 revascularisation 52 nonmelanoma skin cancer 52 NYHA Class II 52 incidence 52 vasospasm 52 genetic polymorphisms 52 aspirin beta blockers 52 Arch Intern Med 52 antihypertensive medication 52 postoperative complications 52 confidence interval #.#-#.# 51 ivabradine 51 streptokinase 51 acute myocardial infarction AMI 51 MGUS 51 liver transplant recipients 51 NTx TM -# 51 coronary heart 51 repeat revascularization 51 cardiovascular disease 51 confidence interval CI 51 intracranial bleeding

Back to home page